Is Higher Dose of Inhaled Treprostinil Truly Superior to Lower Dose of Inhaled Treprostinil in Patients With Pulmonary Hypertension Associated With Interstitial Lung Diseases?

被引：0
|
作者：
Genecand, Leon [1 ]
Lador, Frederic [1 ]
Montani, David [2 ]
Perneger, Thomas [3 ,4 ]
机构：
[1] Univ Hosp Geneva, Dept Med, Div Pneumol, Geneva, Switzerland
[2] Univ Paris Saclay, Hop Bicetre, Pulm Hypertens Natl Referral Ctr, AP AP,Dept Resp & Intens Care Med,INSERM,UMR S 999, Gif Sur Yvette, France
[3] Univ Geneva, Dept Hlth & Community Med, Div Clin Epidemiol, Geneva, Switzerland
[4] Univ Hosp Geneva, Geneva, Switzerland
来源：
CHEST | 2024年 / 165卷 / 05期
关键词：
D O I：
10.1016/j.chest.2023.12.032
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：e161 / e161
页数：1
相关论文
共 50 条
  • [21] Inhaled Treprostinil In Pediatric Pulmonary Arterial Hypertension
    Rosenzweig, E. B.
    Krishnan, U.
    Takatsuki, S.
    Kerstein, J.
    Calderbank, M.
    Ivy, D. D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183
  • [22] Inhaled treprostinil for the treatment of pulmonary arterial hypertension
    LeVarge, Barbara L.
    Channick, Richard N.
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2012, 6 (03) : 255 - 265
  • [23] Rapid Transition from Inhaled Iloprost to Inhaled Treprostinil in Patients with Pulmonary Arterial Hypertension
    Bourge, Robert C.
    Tapson, Victor F.
    Safdar, Zeenat
    Benza, Raymond L.
    Channick, Richard N.
    Rosenzweig, Erika B.
    Shapiro, Shelley
    White, Richard James
    McSwain, Christopher Shane
    Gotzkowsky, Stephen Karl
    Nelsen, Andrew C.
    Rubin, Lewis J.
    CARDIOVASCULAR THERAPEUTICS, 2013, 31 (01) : 38 - 44
  • [24] Systematic evaluation of subgroup analyses of inhaled treprostinil in pulmonary hypertension due to interstitial lung disease
    Martinez-Puig, Pablo
    Baez-Gutierrez, Nerea
    Rodriguez-Ramallo, Hector
    Abdelkader-Martin, Laila
    Otero-Candelera, Remedios
    PLOS ONE, 2025, 20 (02):
  • [25] USING DOBUTAMINE AS A BRIDGE TO INHALED TREPROSTINIL IN SEVERE PULMONARY HYPERTENSION DUE TO INTERSTITIAL LUNG DISEASE
    Ramanan, Siddharth Venkat
    Kumar, Ashwin
    Parikh, Raj
    CHEST, 2024, 166 (04) : 5768A - 5768A
  • [26] Inhaled treprostinil for interstitial lung disease-associated pulmonary hypertension: a silver lining on a very dark cloud
    Cottin, Vincent
    Valenzuela, Claudia
    Humbert, Marc
    EUROPEAN RESPIRATORY JOURNAL, 2023, 61 (06)
  • [27] Efficacy of Inhaled Treprostinil in a Patient with Systemic Sclerosis-Associated Pulmonary Hypertension and Interstitial Lung Diseases Refractory to Conventional Intravenous Epoprostenol
    Hida, Yuki
    Imamura, Teruhiko
    Ushijima, Ryuichi
    Kinugawa, Koichiro
    MEDICINA-LITHUANIA, 2025, 61 (02):
  • [28] Inhaled treprostinil for treatment of chronic pulmonary arterial hypertension
    Voswinckel, R
    Ghofrani, HA
    Grimminger, F
    Seeger, W
    Olschewski, H
    ANNALS OF INTERNAL MEDICINE, 2006, 144 (02) : 149 - 150
  • [29] Inhaled treprostinil in pulmonary hypertension associated with COPD: PERFECT study results
    Nathan, Steven D.
    Argula, Rahul
    Trivieri, Maria G.
    Aziz, Sameh
    Gay, Elizabeth
    Medarov, Boris
    Parambil, Joseph
    Raina, Amresh
    Risbano, Michael G.
    Thenappan, Thenappan
    Soto, Jose Soto
    Bell, Heidi
    Lacasse, Victoria
    Sista, Prakash
    Di Marino, Michael
    Smart, Aimee
    Hawkes, Brittanie
    Nelson, Elizabeth
    Bull, Todd
    Tapson, Victor
    Waxman, Aaron
    EUROPEAN RESPIRATORY JOURNAL, 2024, 63 (06)
  • [30] Safety And Tolerability Of Outpatient Transition Of Parenteral And Inhaled Treprostinil To Oral Treprostinil In Patients With Pulmonary Arterial Hypertension
    Khan, A. A.
    Ackerbauer, K.
    Tandon, R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
12345